Form 8-K - Current report:
SEC Accession No. 0001104659-25-110351
Filing Date
2025-11-12
Accepted
2025-11-12 16:10:31
Documents
15
Period of Report
2025-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K armp-20251112x8k.htm   iXBRL 8-K 37029
2 EX-99.1 armp-20251112xex99d1.htm EX-99.1 199398
3 GRAPHIC armp-20251112xex99d1001.jpg GRAPHIC 3047
  Complete submission text file 0001104659-25-110351.txt   373061

Data Files

Seq Description Document Type Size
4 EX-101.SCH armp-20251112.xsd EX-101.SCH 3524
5 EX-101.DEF armp-20251112_def.xml EX-101.DEF 2860
6 EX-101.LAB armp-20251112_lab.xml EX-101.LAB 16595
7 EX-101.PRE armp-20251112_pre.xml EX-101.PRE 10919
17 EXTRACTED XBRL INSTANCE DOCUMENT armp-20251112x8k_htm.xml XML 4702
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 251472784
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)